The DOI matches its Crossref record.
Diagnostic Histopathology of Tumors
Abstract
When a clinician asks you whether you checked for SS18 gene rearrangement in an otherwise typical biphasic synovial sarcoma, the correct response is, “No, it isn’t necessary”; otherwise we will unwittingly undermine our own profession. —C. D. M. Fletcher, preface to Diagnostic Histopathology of Tumors, 5th edition Six years have elapsed since the previous edition of Fletcher’s Diagnostic Histopathology of Tumors was published. Its newest edition seeks to retain (or attain) a place on the crowded shelves of those among us who seek assistance in practicing the classic art and the changing science of surgical pathology. The book preaches pragmatism, and this philosophy is exemplified by the foregoing advice regarding the potentially gratuitous, if possibly gratifying, test for synovial sarcoma. The attention of Diagnostic Histopathology of Tumors spans from the pedestrian lipoma to the inspired SMARCA4-deficient undifferentiated malignancies. Most newly minted tumor variants (eg, sclerosing mucoepidermoid carcinoma with eosinophilia) and enigmatic disease entities (eg, pleomorphic hyalinizing angiectatic tumor) are addressed. Information on targeted therapy is on offer pro re nata and in an exceptionally crisp chapter entitled “Application of Modern Techniques.” The latest classification systems are applied; however, in a welcome departure from the newest World Health Organization classification, the term “invasive ductal of no special type” is used rather than the hapless nomenclature of “invasive breast carcinoma of no special type.” Any sizable textbook of surgical pathology that spans nearly 2,500 pages and is authored by more than five dozen “global authorities” would be expected to offer ample attention to the diseases most likely to be contended with in routine practice. In this regard, Fletcher’s book mostly delivers. There are other competing multivolume and multiorgan surgical pathology textbooks that offer equally credible content and may be relatively even more expansive (mainly by virtue of including nontumor conditions). True to the title, nonneoplastic ailments are largely skipped. One would have to look elsewhere for deliberation of topics such as inflammatory bowel disease, dysfunctional uterine bleeding, and most infectious diseases. Some of the latter (eg, hepatitis) are discussed only in the context of neoplasms. Nevertheless, notwithstanding the title, macroscopic examination of specimens is accorded its rightful place. Some of the book’s rich pickings are worth sharing in this space. Fletcher reminds us that “to diagnose a tumor in the absence of clear and complete clinical data is foolhardy, dangerous, and sometimes impossible.” Some unsavory trends are bemoaned (eg, “it is troubling that many commercial tests are being marketed directly to clinicians and patients, who are unable to distinguish snake oil from clinically worthwhile testing”). It is opined that trends du jour should not be blindly pursued (eg, “despite bold claims and goals, artificial intelligence and deep learning have had little impact on this field as yet”). One is warned against the obvious snare regarding pathologic diagnosis (ie, “by virtue of simple statistical probability, common things remain common; therefore do not be tempted into an esoteric (or exciting) diagnosis”). Perhaps, the one factor that sets Fletcher’s book apart is the equilibrium between the old and the new, manifested in no small measure throughout its pages. Surgical pathologists of a certain age will take comfort in Fletcher’s assertion that “conventional morphologic and immunohistochemical assessment has continued to hold sway as the preeminent, most reliable, and most effective means of providing a diagnosis and prognostic assessment.” Be that as it may, the forward-looking among us need not be disappointed: the book does detail the utility of SYT-SSX1 and SYT-SSX2 fusion genes in validating the diagnosis of synovial sarcoma whenever conventional pathology is found wanting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Young, R. J., Brown, N. J., Reed, M. W., Hughes, D., & Woll, P. J. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70023-1 · Cited by 962
Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas
Vujovic, S., Henderson, S., Presneau, N., Odell, E., Jacques, T., Tirabosco, R., Boshoff, C., & Flanagan, A. (2006) · The Journal of Pathology · doi:10.1002/path.1969 · Cited by 589
The Wonderful Colors of the Hematoxylin–Eosin Stain in Diagnostic Surgical Pathology
Chan, J. K. C. (2014) · International Journal of Surgical Pathology · doi:10.1177/1066896913517939 · Cited by 449
Expression Profile of MicroRNAs in Serum: A Fingerprint for Esophageal Squamous Cell Carcinoma
Zhang, C., Wang, C., Chen, X., Yang, C., Li, K., Wang, J., Dai, J., Hu, Z., Zhou, X., Chen, L., et al. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.147553 · Cited by 312
Identification of histological threshold concepts in health sciences curricula: Students' perception
Martin‐Piedra, M. A., Saavedra‐Casado, S., Santisteban‐Espejo, A., Campos, F., Chato‐Astrain, J., Garcia‐Garcia, O. D., Sanchez‐Porras, D., Luna del Castillo, J. D. D., Rodriguez, I. A., & Campos, A. (2023) · Anatomical Sciences Education · doi:10.1002/ase.2171 · Cited by 8
Metadata
- Authors
- Hoda, S. A., & Hoda, R. S.
- Venue
- American Journal of Clinical Pathology
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-11-19
- Volume
- 155
- Issue
- 1
- Pages
- 148-149
- ISSN
- 0002-9173 (ISSN-L)
- 1943-7722
- OpenAlex
- W3101207580
- Cited by
- 199
- References
- 0
- FWCI
- 6.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Diagnostic Histopathology of Tumors. https://app.cochat.ai/papers/10.1093/ajcp/aqaa162
- The paper
- Hoda, S. A., & Hoda, R. S. (2021). Diagnostic Histopathology of Tumors. American Journal of Clinical Pathology. https://doi.org/10.1093/ajcp/aqaa162
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.